AveXis (AVXS) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free AVXS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 25, 2023 | finance.yahoo.comNovartis ‘focusing on high-end, innovative medicines,’ CEO saysJanuary 2, 2023 | thestreet.comIonis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen OptionSeptember 21, 2022 | bizjournals.comGoogle-backed gene therapy firm launches Morrisville manufacturing facility - The Business JournalsSeptember 15, 2022 | seekingalpha.comRegenxbio Stock: A Transformative Year (NASDAQ:RGNX) - Seeking AlphaSeptember 12, 2022 | finance.yahoo.comGenSight Biologics Strengthens Its Management Team to Support the Launch of LUMEVOQ® in Europe - Yahoo FinanceAugust 29, 2022 | seekingalpha.comREGENXBIO: Gene Therapy Pioneer Moving To Late-Stage Development (NASDAQ:RGNX) - Seeking AlphaAugust 29, 2022 | dallasnews.comOnce high-flying Dallas biotech sees promising drug data amid growing financial pressure - The Dallas Morning NewsAugust 20, 2022 | bizjournals.comIt's in our DNA: Why the Columbus Region is a hub for gene therapy companies - Columbus Business First - The Business JournalsAugust 17, 2022 | streetinsider.comRelief Therapeutics Appoints David McCullough as Head of U.S. Market Access - StreetInsider.comJuly 20, 2022 | prnewswire.comPopular Open Source GraphQL Company Dgraph Secures $6M in Seed Round with New Leadership - PR NewswireJuly 18, 2022 | globenewswire.comGeneration Bio Appoints Dannielle Appelhans to Its Board of Directors - GlobeNewswireJune 9, 2022 | finance.yahoo.comGlobal Cell and Gene Therapy Market Analysis/Opportunities Report 2022-2035: Niche Startups are Spearheading the Innovation in this Domain - Yahoo FinanceJune 9, 2022 | prnewswire.comGlobal Cell and Gene Therapy Market Analysis/Opportunities Report 2022-2035: Niche Startups are Spearheading the Innovation in this Domain - PR NewswireJune 8, 2022 | globenewswire.comGlobal Cell and Gene Therapy Market Investor/Opportunities Report 2022: Evaluate the Current/Future Potential Over the Coming Decades - GlobeNewswireJune 7, 2022 | seekingalpha.comBLUE stock drives gene therapy stocks higher after FDA review (NASDAQ:BLUE) - Seeking AlphaMay 3, 2022 | finance.yahoo.comSumo Logic Appoints John D. Harkey, Jr. to Board of Directors - Yahoo FinanceApril 21, 2022 | streetinsider.comSatellite Bio Reveals Pioneering Tissue Therapeutics, Bioengineered Tissues That Restore Organ Function, Bringing Hope Across Diseases - StreetInsider.comApril 20, 2022 | seekingalpha.comRegenxbio: Is The Ultimate Catalyst Coming? - Seeking AlphaApril 20, 2022 | businesswire.comSatellite Bio Reveals Pioneering Tissue Therapeutics, Bioengineered Tissues That Restore Organ Function, Bringing Hope Across Diseases - Business WireMarch 29, 2022 | bizjournals.comSamsung invests in Chicago biotech Jaguar Gene Therapy - The Business JournalsMarch 29, 2022 | finance.yahoo.comNkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors - Yahoo FinanceMarch 9, 2022 | finance.yahoo.comTScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities - Yahoo FinanceMarch 7, 2022 | seekingalpha.comTaysha Gene Therapies Gets A 'Thumbs Up' - Seeking AlphaMarch 5, 2022 | theguardian.com'It's a real-life Hunger Games': a lifesaving drug costs $2m, but not every child can get it - The GuardianFebruary 14, 2022 | prnewswire.comNEW STATE AVIATION HOLDINGS NAMES CEO AND CFO - PRNewswireFebruary 11, 2022 | streetinsider.comIxaka Expands Management Team with Multiple Appointments - StreetInsider.comFebruary 2, 2022 | finance.yahoo.comGlobal Cell & Gene Therapy Market Research Report 2022: Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell Therapies - Yahoo FinanceFebruary 2, 2022 | businesswire.comGenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - Business WireFebruary 1, 2022 | streetinsider.comGenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - StreetInsider.comJanuary 19, 2022 | seekingalpha.comWhy I'm Staying Away From Affinia Therapeutics' IPO For Now - Seeking AlphaDecember 21, 2021 | prnewswire.comNEW STATE CAPITAL ACQUIRES AVEX - PRNewswireDecember 17, 2021 | benzinga.comGlobal Cell Gene Therapy Clinical Trials Report 2028 - Benzinga - BenzingaNovember 9, 2021 | finance.yahoo.comBrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs - Yahoo FinanceNovember 8, 2021 | prnewswire.comBrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs - PRNewswireNovember 5, 2021 | barrons.comGene Therapy Is a Huge Opportunity. It Pays to be Patient. - Barron'sNovember 5, 2021 | barrons.comTesting May Take Awhile, but Gene Therapy Is Poised to Tackle Mass Diseases - Barron'sNovember 3, 2021 | globenewswire.com$14,996.35Mn by 2028 Healthcare Regulatory Affairs - GlobeNewswireOctober 30, 2021 | bizjournals.comWhat Jaguar Gene Therapy plans for $125M expansion in Research Triangle Park - Triangle Business JournalOctober 19, 2021 | finance.yahoo.comX4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U.S. Commercial - Yahoo FinanceOctober 5, 2021 | finance.yahoo.comDelix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021 - Yahoo FinanceOctober 4, 2021 | prnewswire.comDelix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021 - PRNewswireSeptember 23, 2021 | finance.yahoo.comGlobal $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements - Yahoo FinanceSeptember 22, 2021 | finance.yahoo.comGlobal Advanced Therapy Medicinal Products (ATMPs) Market to 2028: Focus on CAR-T, Gene, Cell, Stem Cell Therapy - ResearchAndMarkets.com - Yahoo FinanceSeptember 22, 2021 | marketscreener.comCoinFund : Appoints Top Venture Capitalist David Pakman as Managing Partner - marketscreener.comSeptember 14, 2021 | finance.yahoo.com5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal - Yahoo FinanceSeptember 13, 2021 | bizjournals.comRegenxBio, AbbVie sign commercialization deal for Rockville company's eye disease treatment - Washington Business Journal - Washington Business JournalAugust 20, 2021 | dallasnews.comDallas biotech company wins $14.4 million grant from Texas’ cancer research fund - The Dallas Morning NewsAugust 9, 2021 | streetinsider.comAGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site - StreetInsider.com Get AveXis News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. AVXS Media Mentions By Week AVXS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVXS News Sentiment▼0.000.50▲Average Medical News Sentiment AVXS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVXS Articles This Week▼00▲AVXS Articles Average Week Get AveXis News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alvotech News VectivBio News Aclarion News Alpha Tau Medical News American Oncology Network News Aravive News Artelo Biosciences News bioAffinity Technologies News BriaCell Therapeutics News Bullfrog AI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVXS) was last updated on 5/24/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesBiden replacement revealed?Paradigm Press[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaThis could mean the end of the U.S dollar…Colonial MetalsUrgent Nvidia WarningAltimetryWrite this ticker symbol down…StocksToTradeNvidia’s Quiet $1 Trillion PivotWeiss RatingsA personal note from Behind The Markets' CEO Dylan Jovine...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AveXis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.